Cohen JS, Levy HP, Sloan J, Dariotis J, Biesecker BB.
Depression among adults with neurofibromatosis type 1: prevalence and impact on
quality of life. Clin Genet 2015;88(5):425–30. https://www.ncbi.nlm.nih.gov/pubmed/25534182
Descheemaeker MJ, Plasschaert E, Frijns JP, Legius E.
Neuropsychological profile in adults with neurofibromatosis type 1 compared to a
control group. J Intellect Disabil Res 2013;57(9):874–86. https://www.ncbi.nlm.nih.gov/pubmed/23095048
Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG,
et al. Guidelines for the diagnosis and management of individuals with
neurofibromatosis 1. J Med Genet 2007;44(2):81–8. https://www.ncbi.nlm.nih.gov/pubmed/17105749
Friedman, J. Neurofibromatosis 1. In: GeneReviews
[Internet]. Seattle, WA: University of Washington, Seattle; 1998 (updated 2019).
https://www.ncbi.nlm.nih.gov/books/NBK1109/
Hamoy-Jimenez G, Kim R, Suppiah S, Zadeh G, Bril V, Barnett
C. Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.
Neurooncol Adv 2020;2(Suppl 1):i141–i9. https://www.ncbi.nlm.nih.gov/pubmed/32642740
Howell SJ, Hockenhull K, Salih Z, Evans DG. Increased risk
of breast cancer in neurofibromatosis type 1: current insights. Breast Cancer
(Dove Med Press) 2017;9:531–6. https://www.ncbi.nlm.nih.gov/pubmed/28860858
Miller, DT; Freedenberg, D; Schorry, E; Ullrich, NJ;
Viskochil, D; Korf, BR, et al. Health supervision for children with
neurofibromatosis type 1. Pediatrics 2019; Vol 143(5). https://www.ncbi.nlm.nih.gov/pubmed/31010905
Stewart, DR; Korf, BR; Nathanson, KL; Stevenson, DA; Yohay,
K. Care of adults with neurofibromatosis type 1: a clinical practice resource of
the American College of Medical Genetics and Genomics (ACMG). Genet Med 2018;
Vol 20(7):671–82. https://www.ncbi.nlm.nih.gov/pubmed/30006586
Tsirikos AI, Saifuddin A, Noordeen MH. Spinal deformity in
neurofibromatosis type-1: diagnosis and treatment. Eur Spine J
2005;14(5):427–39. https://www.ncbi.nlm.nih.gov/pubmed/15712001
